Written by Nancy Fliesler

A mixed population of T cells (CD4+ cells) from a mouse. Red stain indicates that DEPTOR is turned on. Cell nuclei appear in blue. Photo credit: Johannes Wedel/Briscoe lab

A pair of new studies led by investigators at Harvard Medical School and Boston Children’s Hospital looks to T cells as paths toward reducing organ transplant rejection and treating autoimmune diseases.

The immune system has two major kinds of T cells. T helper cells, also known as effector T cells, tend to rev up our immune responses, while T regulatory cells tend to suppress or downregulate them. Read more.

Published July 27, 2018 by Harvard University

Share this story